Human genome editing: how to prevent rogue actors.

Area of Science:

• Genetics and Genomics
• Bioethics
• Biotechnology Regulation

Background:

• Human genome editing technologies present significant ethical, legal, and social challenges.
• Recent misuse of these technologies by certain actors has heightened concerns.
• Public and expert caution is advised regarding human germline genome editing and its intergenerational impact.

Purpose of the Study:

• To explore methods for regulating genomic editing to be socially beneficial.
• To address concerns about curtailing 'rogue actors' in heritable genome editing.
• To evolve regulatory frameworks considering legal, ethical principles, and human rights.

Main Methods:

• Analysis of existing and potential regulatory frameworks across jurisdictions.
• Examination of socially beneficial approaches to genomic editing regulation.
• Development of practical recommendations for governance structures.

Main Results:

• Proposed regulatory measures must be robust, culturally sensitive, inclusive, appropriate, and trustworthy.
• Effective governance requires a combination of 'hard' law (national/supranational regulation) and 'soft' ethics.
• Rigorous, practical, and robust efforts supporting legal and ethical solutions are necessary.

Conclusions:

• Harmonization across jurisdictions and increased public engagement are crucial for effective regulation.
• A normative framework combining legislation and ethics, anchored in human rights, can prevent future misuse.
• Balancing innovation benefits with public health safeguards requires careful, rights-based stewardship.